year,stock,source,target,sublist.holder,sublist.location,sublist.is_coreSource,sublist.table_source1,sublist.table_source2,sublist.table_source3,sublist.table_source4,market,group,taxcode.source,taxcode.target,china.note,X1,修正,非集團
2016,4737,華廣生技股份有限公司,Bionime Australia Pty Limited,1,澳大利亞,1,1,0,0,0,上市,G4737,80310225,NA,NA,NA,NA,NA
2016,4737,華廣生技股份有限公司,Bionime GmbH,1,瑞士,1,1,0,0,0,上市,G4737,80310225,NA,NA,NA,NA,NA
2016,4737,華廣生技股份有限公司,Bionime Incorporated,1,英屬維京群島,1,1,0,0,0,上市,G4737,80310225,NA,NA,NA,NA,NA
2016,4737,華廣生技股份有限公司,Bionime USA Corporation,1,美國,1,1,0,0,0,上市,G4737,80310225,NA,NA,NA,NA,NA
2016,4737,華榮電線電纜股份有限公司,華廣生技股份有限公司,NA,NA,0,0,0,0,1,上市,G4737,79460007,80310225,NA,NA,NA,NA
2016,4737,通化東寶藥業股份有限公司,華廣生技股份有限公司,NA,NA,0,0,0,0,1,上市,G4737,NA,80310225,NA,NA,NA,NA
2016,4737,華廣生物科技(深圳)有限公司,華廣生物技術(平潭)有限公司,1,china,0,1,0,1,0,上市,G4737,NA,NA,NA,NA,NA,NA
2016,4737,Bionime Incorporated,華廣生物科技(深圳)有限公司,1,china,0,1,0,1,0,上市,G4737,NA,NA,NA,NA,NA,NA
